Skip to content

Peripheral Facial Paralysis Sequelae in Lyme Disease Among Children

Comparative Study of Peripheral Facial Paralysis Sequelae Based on the Initial Medical Care of Lyme Disease Among Children

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03981874
Acronym
LYMEPED
Enrollment
50
Registered
2019-06-11
Start date
2019-05-29
Completion date
2019-07-29
Last updated
2019-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lyme Disease

Keywords

neuroborreliosis, facial palsy, children

Brief summary

Neuroborreliosis (NB) is the second most frequent manifestation of Lyme disease. Painful meningoradiculitis is the most common neurologic manifestation in adults while facial nerve palsy (FP) and lymphocytic meningitis is predominant in children. FP is a common reason for pediatric consultation and FP due to Lyme borreliosis (LB) represents about 50% of the child's FP in an endemic area. The action to be taken is not formally defined for a child consulting for FP in a Lyme disease endemic area. The new recommendations of the High Authority of Health of June 2018 recommend to carry out a blood serology in first intention, in search of a NB in a child consulting for a peripheral facial paralysis. If this is positive, a lumbar puncture will be performed in search of meningitis. In the case of negative serology, a close clinical surveillance and sometimes serological control is necessary, in order to reassess the diagnosis. In adult recommendations, a lumbar puncture is performed first in any patient consulting for facial paralysis in LB endemic area. The main objective of this study was to describe the clinical and biological characteristics of pediatric NB with FP. Others objectives were to describe the diagnostic and therapeutic behavior of a child consulting at university hospital for a facial nerve palsy, to compare the initial gravity of facial nerve palsy, the duration of the paralysis and sequels depending on the diagnosis and treatment initiated.

Interventions

Telephonic interview

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children consulting for peripheral facial palsy

Exclusion criteria

* Children consulting for central facial palsy * Children with congenital peripheral facial palsy * Children with surgery and trauma in the area of the facial nerve, * Children with peripheral facial palsy with previous diagnosis * Children whose parents refuse the study participation

Design outcomes

Primary

MeasureTime frameDescription
Assesment of persistent sequelae4 yearsFacial paralysis duration assesment and persistence of physical sequelae at time of the telephonic call using House & Brackmann classification for facial function. This grading system has 6 levels, used for middle- to long-term monitoring: I. Normal II. Mild dysfunction III. Moderate dysfunction IV. Moderately severe dysfunction

Countries

France

Contacts

Primary ContactCandice Feuillebois, Int
sydnak@hotmail.fr+33381218516
Backup ContactRaphael Anxionnat, MD
ranxionnat@chu-besancon.fr+33381218516

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026